News
Important Only
Novocure To Present Data From Phase 3 Panova-3 Trial Of Tumor Treating Fields In Pancreatic Cancer At Esmo Gastrointestinal Cancers Congress 2025
July 1 (Reuters) - Novocure Ltd NVCR.O:NOVOCURE TO PRESENT FINAL SECONDARY ENDPOINT DATA FROM THE PHASE 3 PANOVA-3 TRIAL OF TUMOR TREATING FIELDS (TTFIELDS) IN PANCREATIC CANCER AT THE ESMO GASTROINTESTINAL CANCERS CONGRESS 2025Reuters
Tue, Jul 1
Edap Tms SA To No Longer Qualify For Foreign Private Issuer Status Effective Jan 1, 2026
July 1 (Reuters) - Edap Tms SA EDAP.O:EDAP TMS SA - TO NO LONGER QUALIFY FOR FOREIGN PRIVATE ISSUER STATUS EFFECTIVE JAN 1, 2026EDAP TMS SA - TO COMPLY WITH SEC AND NASDAQ RULES FOR U.S. DOMESTIC FILERSReuters
Tue, Jul 1
Verrica Pharmaceuticals - To Receive $8 Million Milestone Payment In July 2025
July 1 (Reuters) - Verrica Pharmaceuticals Inc VRCA.O:VERRICA PHARMACEUTICALS ANNOUNCES AMENDMENT TO COLLABORATION AND LICENSE AGREEMENT WITH TORII PHARMACEUTICAL TO LAUNCH GLOBAL PIVOTAL PHASE 3 CLINICAL TRIAL TO STUDY YCANTH® FOR THE TREATMENT OF COMMON WARTSVERRICA PHARMACEUTICALS INC - TO RECEIV...Reuters
Tue, Jul 1
Yy Group Holding Limited Strengthens Ifm Division With Acquisition Of Pesticide Pest Control Pte
July 1 (Reuters) - YY Group Holding Ltd YYGH.O:YY GROUP HOLDING LIMITED STRENGTHENS IFM DIVISION WITH ACQUISITION OF PESTICIDE PEST CONTROL PTE. LTD.YY GROUP HOLDING LTD - PROJECTS REVENUE TO INCREASE TO S$96.0 MILLION BY 2028Reuters
Tue, Jul 1
Blackstone's gambling co Cirsa expects share listing in Spain on July 9
MADRID, July 1 (Reuters) - Blackstone's BX.N gambling company Cirsa intends to have its shares listed on the Spanish stock market on or around July 9, it said on Tuesday after the stock market regulator CNMV authorised the planned initial public offering. The company said on Monday it would seek...Reuters
Tue, Jul 1
Bioxcel Receives Second Positive Recommendation To Continue Phase 3 Trial For Treatment Of Agitation Associated With Schizophrenia
July 1 (Reuters) - BioXcel Therapeutics Inc BTAI.O:BIOXCEL THERAPEUTICS RECEIVES SECOND POSITIVE RECOMMENDATION FROM DATA SAFETY MONITORING BOARD (DSMB) TO CONTINUE SERENITY AT-HOME PIVOTAL PHASE 3 SAFETY TRIAL FOR ACUTE TREATMENT OF AGITATION ASSOCIATED WITH BIPOLAR DISORDERS OR SCHIZOPHRENIABIOXCE...Reuters
Tue, Jul 1
Apellis To Receive Up To $300 Million From Royalty Purchase Agreement With SOBI
July 1 (Reuters) - Apellis Pharmaceuticals Inc APLS.O:APELLIS TO RECEIVE UP TO $300 MILLION FROM ROYALTY PURCHASE AGREEMENT WITH SOBI FOR EX-U.S. ROYALTIES OF ASPAVELI® (SYSTEMIC PEGCETACOPLAN)APELLIS PHARMACEUTICALS INC - RETAINS FULL U.S. COMMERCIALIZATION RIGHTS FOR SYSTEMIC PGCETACOPLANAPELLIS P...Reuters
Tue, Jul 1
Adagene Announces Up To $25 Million Strategic Investment From Sanofi
July 1 (Reuters) - Adagene Inc 978y.F:ADAGENE ANNOUNCES UP TO $25 MILLION STRATEGIC INVESTMENT FROM SANOFIPROCEEDS EXPECTED TO EXTEND CASH RUNWAY INTO 2027ADAGENE ANNOUNCES UP TO $25 MILLION STRATEGIC INVESTMENT FROM SANOFISANOFI HAS AGREED TO MAKE STRATEGIC INVESTMENT OF UP TO US$25 MILLION IN ADAG...Reuters
Tue, Jul 1
Morning News Call - U.S., July 1
To access a PDF version of this newsletter, please click hereYou can read Morning News Call -- US via TOPNEWS U.S. Companies page.If you would like to receive this newsletter through your email, please register at:https://solutions.lseg.com/MorningNewsCallEN-subscription-pageFor Morning News Call Ca...Reuters
Tue, Jul 1
CORRECTED-PRESS DIGEST - Wall Street Journal - July 1
July 1 (Reuters) - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.- California lawmakers on Monday night rolled back one of the most stringent environmental laws in the country, after Gov. Gavin Newsom muscle...Reuters
Tue, Jul 1
